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Mounier-Kuhn syndrome or congenital tracheobronchomegaly is a chronic airway condition
which for currently unknown reasons mostly affects males. It is commonly overlooked on con-
ventional chest X-rays, and is considered to be rare, but the prevalence might be higher as
commonly assumed. The hallmark of it is a dilatation of the main airways which frequently,
but not always, causes marked, mainly respiratory, symptoms, and patients usually present
with varying degrees of recurrent infections, breathlessness, haemoptysis, dyspnoea. Although
at least 200 case reports have been published, there have been only a few attempts to review
them, and none in the last 20 years. Due to the lack of clinical trials and wide variability of
case-report format, a systematic review was deemed not feasible, therefore PubMed and Med-
line databases were searched using terms “Mounier-Kuhn syndrome”, “tracheobronchome-
galy”, “tracheomegaly”, and “bronchomegaly”, without any time restrictions, to summarize
currently known facts about the syndrome. To the authors’ best knowledge, the result is
currently the most comprehensive review of previously published literature about the congen-
ital tracheobronchomegaly, and summarizes what’s known about symptoms, prevalence, dis-
ease associations, and treatment options for this syndrome. TBM e tracheobronchomegaly,
MKS e Mounier-Kuhn syndrome, CT e computed tomography, COPD e chronic obstructive pul-
monary disease.
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The histological findings of enlarged airways were
described already in 1897 [S1] but only in 1932 the first
clinical description was made [S2]. Many similar cases of
trachea- and bronchomegaly have been subsequently pub-
lished, both as isolated cases and as cases where it goes
together with some other condition. With greater recogni-
tion of the syndrome, it is the latter type of reports that are
becoming increasingly more common. But, despite the
growing number of cases published, reviews of them are
few. The first comprehensive review articles were first
published in 1962 (by then the eponym Mounier-Kuhn syn-
drome (MKS) was already in use) [1] and in 1965 [2]. Some
thirty years later a report of a series of ten cases again
reviewed the most important characteristics of the syn-
drome [3], but none of authors, since Katz [1] & Johnston
[2], have attempted to create a comprehensive review of
available literature on the MKS. Most of them cite just a
handful of articles published up to now. More importantly,
the number of case reports published since the last review
has increased significantly, including a variety of new
treatment options for these patients. The first descriptions
of long-term follow-up start to emerge and at least onee 1 Airway dimensions of adults, normal values, mm.
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ge for males/females separately not given in the publication.clinical trial has been conducted since the last review in
1991. Due to the lack of clinical trials or epidemiological
studies and wide variability of published case reports, we
lacked an appropriate basis for a systematic review and
therefore the following pages summarize the current
knowledge about the MKS as can be concluded from pub-
lished cases e by presenting both the available facts and
contradictions about the pathogenesis, symptoms and
possible management of the disease, showing the wide
variability of the MKS and different problems caused by it.Methods of literature search and description of
results
Both EK and ZK independently searched the PubMed and
Medline databases for the terms “Mounier Kuhn syndrome”,
“Tracheobronchomegaly”, “Tracheomegaly” or “Broncho-
megaly”. No publication date restrictions were used. Ab-
stracts were then reviewed to identify any relevant
publication and full text was then retrieved if it was esti-
mated that it would provide valuable additional informa-
tion. If opinions of EK and ZK differed the opinion of AB was
deciding. A similar search was made in Google Scholar andTrachea Left main
bronchus
Right main
bronchusSagittal section Coronal section
24.7 28.6 22.5 23.8
27 25 e e
23 21 e e
27.4 24.9 e e
21 20 e e
e e 18.4 21.1
e e 17.4 19.8
1824 E. Krustins et al.references of the acquired articles were reviewed to
identify any additional publication. If the language of an
article wasn’t English, German or Russian, possibility of
translation was evaluated. Publications not-indexed in
PubMed or Medline were considered if in authors’ opinion
they provided relevant information to this review.
A search for MKS in PubMed returned over 260 results
and most were about the syndrome in question. Published
articles ranged from reports of single patients with typical
symptoms and/or associations with other diseases to a few
articles presenting a series of up to ten patients [3e5]. A
single clinical trial has been conducted [5]. Only a few
authors have followed patients for more than a year
[S3,S4], most authors are describing patients at the time
when their diagnosis was made. Majority of articles are
published in English but there are reports available in many
languages [6], [S5eS19].Review
Defining normal airways
The first review defined the MKS as “a distinctive clin-
icaleroentgenologic condition consisting of marked dilata-
tion of the trachea and major bronchi and associated with
chronic respiratory tract infections” [1]. But to understand
what is enlarged or dilated trachea one first has to agree
upon what is the size of normal airways and several studies
have attempted that.
Table 1 shows studies on normal airway values in adults
(discussing details about the children is beyond the scope of
this paper and the interested reader is referred to the
works of Griscom [S20eS22] or de Jong [S23]). Most
importantly, in 1984 [7], using the conventional chest X-
rays, it was found that the size of the trachea was depen-
dent only from the gender, and not from the body mass or
height. The author, assuming that the size of a human
trachea follows a normal distribution, suggested that the
upper limit should be two standard deviations above the
average values, when measured 2 cm above the projected
top of the aortic arch (although no significant differences
were noted in measurements on other levels) [7]. No
bronchial measurements were done in this study. These
were added later [3] (Table 1).
A study of 150 patients in 1994 confirmed that the same
values can be used to evaluate measurements done by
CT [8].Table 2 Prevalence studies for TBM.
Author Year Prevalence
Fiser [S27] 1969 6 cases in 1200
Abramovic [S28] 1970 3 cases in 500 b
Himalstein [S24] 1973 5 cases in 500 b
Bateson [S26] 1973 2 cases in 120 b
Acimovic [S29] 1994 4 cases in 396 b
Roditi [8] 1994 7/42 CTs of pat
Cartier [S30] 1998 1/82 CTs of pat
Menon [4] 2008 8/5234 pulmonGeneral characteristics in MKS
The typical histological findings of MKS were summarized by
Katz already in 1962 [1]. The thinning of muscular mucosa,
as well as the atrophy of longitudinal muscle and elastic
fibres are universal and accepted hallmarks of MKS [1],
[S25]. Numerous saccular diverticula between cartilages,
and bulging and spindle shaped dilatations in the posterior
wall may be seen. It’s assumed that these arise when
redundant non-muscular segments protrude between the
transverse bands of muscle that connects the tips of U
shaped tracheal cartilages [1]. The absence of myenteric
plexus in the tracheal wall may suggest a condition similar
to Hirschprung’s disease or achalasia of gastric cardia [S26].
A suggestion to classify all cases of TBM in three types
based on anatomical appearance has been made [S24].
Type I would have symmetrical diffuse enlargement of both
trachea and bronchi. In the most common e Type II, the
enlargement is more eccentric with pronounced diverticula
and abrupt change to normal bronchial size. Lastly, the
Type III, where diverticula may extend to the more distal
bronchi but only few case-reports have used it.
To the best knowledge of the authors no population
based studies of MKS have been published so far. But some
publications estimate a prevalence between 0.4 and 1.6%
(Table 2) in patients with pulmonary symptoms.
Nevertheless the 7 cases out of 10 reported by Woodring
[3] that were found accidentally, and the fact that enlarged
trachea is easily overlooked in chest X-ray [S31] casts doubt
whether the syndrome is really so rare. The number of
published case reports grows steadily e a possible sign of
greater awareness. Additionally, intentional searching for
cases would identify minimal tracheal enlargement that
would otherwise remain overlooked [8].
MKS may be mistaken with Williams-Campbell syndrome
[S32], a congenital deficiency of the 4th to the 6th order
bronchial cartilages [S33]. But on CT scans the bronchial
defects of the Williams-Campbell syndrome begin at the
bronchi of the 4th order division e a level where the
enlarged airways of MKS should return to normal and in
Williams-Campbell syndrome the collapse of cystic bron-
chial dilatations can be observed in expiratory CT scans
[S34,S35].
The age of patients with MKS varies greatly: from a 18
months old girl [S36] and a 19 months old boy [S37] to an 86
years old [S38] man (a case of a 15 months old boy [S39]
with involvement of the bronchi of sixth and seventh divi-
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of life; In one report [2] the average age of patients was 39
years, and in two others [3,4] e 56 years. But it’s not un-
common that patients are diagnosed only in their 70-ties
[S40], despite a long history of respiratory symptoms, as
shown by the case of the 79 years old woman, who was
diagnosed with chronic obstructive pulmonary disease
(COPD) despite being life-long non-smoker and with no
relevant occupational history [S41].
There is a strong male predominance of about 8:1 [2,4]
and most of the patients seem to be smokers, although
life-time non-smokers have been reported [3], [S41,S42]. A
possibly accidental predominance in Afro-American pa-
tients has been noted [S26].
The origin of MKS seems to be congenital, as confirmed
by the histo-pathological data, in association with recur-
rent childhood infections and occasional occurrence of MKS
together with several congenital disorders. A description of
two siblings with MKS [2] and a possible case of MKS among
cousins [3] has caused some to think of autosomal recessive
disorder [2].
Although the previously cited definition does not
mention the possible aetiology, the authors of this review
hold the opinion that only cases without any clear cause
should be labelled as MKS and patient’s history should be
carefully taken and reviewed if TBM is suspected as a list of
conditions may cause acquired TBM: pulmonary fibrosis
[10], [S43], mechanical ventilation [S44] especially for
preterm neonates [S45] and radiotherapy [S46]. TBM due to
the pulmonary fibrosis may be less marked as in cases
without a clear cause [10]. Additionally several immuno-
deficiency syndromes in children [S47] have been associ-
ated with TBM. Neonatal TBM is a common complication
following intrauterine tracheal occlusion [S48,S49]. A case
secondary to tuberculosis has been published, but the
airway size was not given [S50].Table 3 List of diseases reported together with MKS.
Adrenal insufficiency [S63]
Amyloidosis, Type AA, Secondary [S13]
End-stage renal disease (due to arterial hypertension
with renal transplantation) [S3]
Fibrous histiocytoma [S64] a
HIV [S10]
IgA nephropathy [S65]
Isolated adrenocorticotrophic-hormone deficiency [S66]
Laryngeal cancer [S67]
Light chain deposition disease [S17]
Non-small cell carcinoma [S68]




Renal tumour [S65] b
Tracheopathia osteoplastica [S73]
T-cell lymphoma [S38]
a Publication had no data about the airway size.
b No further information available.Associations with other diseases
Several case reports mention congenital defects, including
accessory tracheal bronchi [S19,S27,S29,S51], but as for
one report [S51] the airway size is not given, the criteria for
the syndrome can’t be verified. TBM has been described in
3 cases of Brachmann-de Lange [S52], in a case of Kenny-
Caffey syndrome [S53] and one case includes abnormal
bronchial vasculature [S29].
There are cases of TBM reported together with Ehlers-
Danlos [11], [S54] and Marfan’s [S55] syndromes and cutis
laxa [S56] as well as rheumatologic disorders e ankylosing
spondylitis [12], [S42,S57,S58] (although for one study [S58]
the criteria of tracheobronchial dilation are not clear) and
two patients with rheumatoid arthritis [13,14]. In a child
with Ehlers-Danlos syndrome [S59] the airway size didn’t
quite reach the criteria for MKS but it can’t be excluded
that the trachea might have enlarged further reaching the
necessary criteria of TBM. To complicate things further, a
patient with Marfan’s syndrome developed a significant
tracheomegaly after therapeutic irradiation [S60]. And
there is a list of indistinct cases where the accompanying
disease of MKS has not been clearly diagnosed [15],
[S19,S61,S62].
Table 3 lists the conditions reported together with MKS
that most likely should be looked at as separate problems
(in alphabetical order).Clinical findings of MKS
The complaints are non-specific and largely related to the
infectious consequences of the disease. In many patients
they begin in third decade of life. Chronic, recurrent res-
piratory infections with productive or dry cough [S40] and
purulent sputum, dyspnoea (occasionally on exertion) [S74]
and haemoptysis [5], [S16,S29] all seem to be common.
Some patients have had recurrent infections since early
childhood [6] and others are diagnosed accidentally [16],
[S75] having had no symptoms yet, but it seem that only a
handful remain symptom-free lifelong. The recurrent res-
piratory complaints frequently are interpreted as caused by
COPD, even when no criteria support it [17], [S41]. In
developing countries some have received empiric therapy
for tuberculosis [18], occasionally without evidence of the
presence of tuberculous bacteria [S76,S77]. Progressive
hoarseness, caused by vocal cord paralysis, possibly due to
changed crycoarytenoid joint, has been described [S61].
It is unclear whether the TBM is progressive. Only two
patients have been observed from childhood to adulthood.
One was first diagnosed with asthma at the age of 4. Bron-
chiectasis were noted at the age of 13, and after four years
MKS was diagnosed [S4]. The other was diagnosed at the age
of 11 [S3] and the tracheal size didn’t change significantly in
later years. One adult case with TBM [S78] had no increase in
the tracheal size over 8 years, but the patient had pulmonary
fibrosis which can cause acquired TBM [10], [S43].
Upon clinical examination, finger clubbing is common,
and bronchial rales and/or wheezing can be heard upon
auscultation. Fever, chills, tachypnoea and tachycardia
may be present during exacerbations. Gastroesophageal
reflux disease [5] may be present and the syndrome may
1826 E. Krustins et al.contribute to or at least exacerbate symptoms of the sleep
apnoe [S79].
Varying degree of obstruction and an increased residual
capacity are noted on spirometry [15] and values are lower
during the infectious exacerbations [6] but respiratory
function may be normal [S9]. Together with dynamic CT,
spirometry can help documenting tracheal collapse [S80].
TBM is visible on plain chest X-rays [3] where the
tracheal size may exceed the width of the vertebral column
[1], [S54], but it’s not uncommon to miss it altogether until
a CT is done [17]. An abrupt change from dilated to normal
calibre bronchi in peripheral airways has been noted with a
suggestion that in acquired bronchomegaly the airways
would dilate symmetrically [9]. CT has become the golden
standard for confirming the diagnosis since its first use for
MKS in 1988 [19], [S81,S82]. Use of magnetic resonance
imaging is limited to one case-report, and provided no
significant additional information [20].
During bronchoscopy the increased tracheal diameter
and the expiratory collapse due to tracheomalacia [S83] is
seen and the redundant tracheal wall may even obstruct
the view [1]. In an endobronchial confocal fluorescence
microscopy a patient with MKS had intense bronchial
autofluorescence and decreased general fluorescence in-
tensity, with spectral shape of normal tissue, that, ac-
cording to the authors of the study, suggests the
disappearance of the fibred connective network of the
bronchial wall [21].
The variability of the disease is at best represented by
both cases of long-term follow-up. The one patient suffered
recurrent feverish respiratory infections but retained
normal pulmonary function [S3] whereas for the other fever
was uncommon but the pulmonary function steadily dwin-
dled reaching severe obstruction [S4].
The bullous emphysema is common in MKS and may
cause pneumothorax [11], [S84eS86] in otherwise asymp-
tomatic patients with TBM [S14]. It has been suggested that
these cases should be treated alike along the guidelines for
secondary pneumothorax in COPD [S84].
Two cases of aspergillosis andMKS are known. In one case,
in which aspergillosis was diagnosed after pulmonectomy
due to massive bleeding [S16], the MKS was already diag-
nosed but in the second case TBM and the allergic aspergil-
losis were diagnosed at the same time [S87].Surgery and anaesthesia
MKS causes difficulties across many specialities but espe-
cially anaesthetist’s work is complicated by the large and
weak airways, inefficient cough mechanism, tracheal
diverticula, endotracheal tube dislodgement and possible
postoperative tracheal collapse [16], [S63]. Endotracheal
tube cuff-leak during endotracheal intubation might be the
first sign of MKS [S70,S88]. A partial oesophagectomy had to
be completed with partially deflated lung due to persistent
inability to achieve air-seal during the intubation [S70]. A
marked tracheal stenosis after intubation of a patient with
TBM demanded surgical intervention [16] so the use of
uncuffed endotracheal tube was suggested [16] or the
laryngeal mask may be used [S72]. An excellent review of
possible solutions while providing anaesthesia to MKSpatients is given by Kim et al. [S44]. But not all cases of TBM
have operative complications [S3,S65,S75].
A study, including some patients with MKS, showed that
surgical tracheobronchoplasty may be used to correct tra-
cheomalacia [22]. And several patients with TBM have had
other surgical interventions with varying degrees of suc-
cess: uneventful renal transplantation [S3], nephrectomy
[S65], lower left pulmonary lobectomy [S89] and pulmo-
nectomy [S16], an elective repair of epigastric hernia [S90],
septoplasty [S63], an emergency off-pump coronary bypass
[S75], and bilateral resection of pulmonary bullae via me-
dian sternotomy approach [S91] all have been reported.
One patient with TBM developed hernia of the lung through
thoracic wall, after resection of a non-small cell carcinoma
[S68].Treatment options
Mucolytic treatment and physical therapy, including mas-
sage and postural drainage, have been used to counteract
the decreased clearing ability of bronchial tree, to increase
the separation of the sputum and to facilitate expectora-
tion. It has been noted that a pneumococcal polysaccharide
vaccine provides at least a temporary relief [S4] and
vaccination against influenza has been previously suggested
[23].
Trachebronchomalacy is present when more than 50% of
the airway collapse during expiration [24] and alone [S92]
or when complicated by stenosis [S83] it may cause
serious breathing problems. Non-invasive continuous posi-
tive airway pressure ventilation has shown promising re-
sults in reducing the symptoms and treatment was
successful in several cases of TBM [18], [S83,S92]. About
8e10 mmHg positive airway pressure is usually sufficient
[18], [S92].
Airway stenting and/or tracheobronchoplasty for tra-
cheomalacy is supported by several trials [24,25] which
have included patients with MKS. One trial included 3 pa-
tients with TBM and showed that silicone stents improve
respiratory symptoms and quality of life in patients with
tracheobronchomalacy [25]. A single patient was included
in a report of advantages of tracheal T-tube which sug-
gested that tracheal T-tube ought to be the preferred
management for chronic airway obstruction, if it cannot be
corrected by surgery [S93]. One clinical trial (with 12 pa-
tients) showed [5] that an aggressive approach with airway
stenting and surgical tracheobronchoplasty achieves better
results than supportive measures alone [5].
Good results with tracheal stenting are seen in single
case reports. Y shaped silicone stent achieved full reha-
bilitation in social and professional life for a patient with
both TBM and tracheal stenosis [S83]. Marked improvement
was achieved with a self-expanding metal [S7] and a Dy-
namic [S94] stent. In the latter case the result persisted at
least for a year. Symptoms improved in another case but
the type of stent and the extent of improvement were not
given [S5]. Availability of appropriate airway stent may be a
significant problem as the diameter of most commercial
stents does not exceed 20 mm [S55], although these have
been used with good results in exceedingly large (up to
42 mm) airways. A custom made stent may be used [S55].
Mounier-Kuhn syndrome e a review 1827In one case the posterior wall collapse has been suc-
cessfully treated with Endoscopical laser treatment. Four
procedures over 8 years achieved good results [26]. Laser
devascularizes and coagulates the tissue causing a retrac-
tion of submucousa which rigidifies the posterior membrane
of trachea [26].
Lung transplantation has been reported twice: a bilat-
eral lung transplantation in a patient with 27 years of pul-
monary symptoms and rheumatoid arthritis [14] and in a
patient, whom the MKS was diagnosed in the explanted
lungs [27]. Both patients died soon after the trans-
plantation [28]. It is interesting that Ng [S88] mentions
another patient with mild TBM who had received a double
lung transplant. Unfortunately no additional information is
given, but if this is true it seems to be the only and unre-
ported successful lung transplantation in a MKS patient.Discussion and conclusions
At least two decades have passed since the last significant
review of the available literature on MKS, published in 1991
[3]. Now MKS has been found in all age groups further
strengthening the hypothesis that a congenital cause should
be suspected. Some patients now are followed over a
course of several years giving insights about the course of
the disease and future prognosis for other patients. The
symptoms reported haven’t changed much since but di-
agnostics of the MKS and ability to help these patients have.
The use of CT has enabled a better and easier visualization
and determination of airway size, facilitating recognition of
obviously abnormal cases. But as the airway measurements
don’t seem to be a routine assessment, it is not known how
many cases just above the upper normal limit are missed.
During the last 20 years, the new data about interventional
strategies are the most important addition to the literature
on MKS. Bronchoscopic treatment has developed quickly
since 1991 and stenting now provides at least some relief to
patients with MKS. Also surgical treatment has advance
somewhat. And the fact that a clinical trial has been done,
promises that evidence based recommendations may be
available one day.
There is nothing much new that can be said about
possible aetiology of MKS. Published cases still support the
theory that MKS is a congenital defect but no new data has
been published to better understand the cause of dilation.
The authors of this review suspect it to be a multifactorial
genetic effect, which causes the changes in airways with
subsequent symptoms. The only publication on familial
occurrence seems to be peculiarity and not a proof of he-
redity. Also the border between primary and secondary
disease remains to be clarified.
The strength of this review lies in the comprehensive
summary of previous publications about MKS, in the sheer
number of cases reviewed and in the fact that the authors
haven’t limited their search only to English language. As the
number of cases reported since the last review [3] has
grown, so has the diversity of diseases encountered
together with MKS, expanding experience of the treatment
for these patients. But currently it is still impossible to say
which cases are coincidental with MKS and if there are any
conditions in which MKS is truly more common.Some authors have assumed that in cases of rheumato-
logic and connective tissue diseases MKS should be consid-
ered to be secondary [4,8], [S96] but the authors of this
review believe that it remains yet to be confirmed, as there
are just few reports for each of the connective/rheuma-
tologic diseases.
The authors of this review rebut a common misconcep-
tion about the number of MKS cases published worldwide.
The most common number mentioned is around 100 cases,
which seems to be caused by careless citation; for example,
an article [S97] stated this number in 2011, and cited a
publication from 1994 [S42] which itself further referred to
an article published in 1988 [S81]. A quick search in PubMed
reveals more than 200 cases. The authors of this review
estimate that there could be at least 300 cases published so
far, if not more.
There are, of course, weaknesses to this review. First of
all, it is based on case reports and lacks support of clinical
trials. To the best knowledge of the authors every aspect of
MKS has been included in this review but important details
might have been missed, as articles that are not indexed in
PubMed or Medline might still harbour important facts. Only
what has been published so far can be reviewed and as seen
from the example above e an important fact (successful
lung transplantation) might not have been reported. The
suspicion that this syndrome is under-reported only in-
creases the doubt.
Data from trials are scarce and limited to specific pa-
tient groups. As the syndrome remains relatively rare and it
is unlikely that any large scale systematic study will be
conducted anytime soon, the authors of this review suggest
that future publications should try to standardize reported
clinical findings in order to decrease the wide variability
observed in previous case reports. Patient’s demographics
(age, gender, and length of complaints, smoking status and
pack years), clinical findings (including finger clubbing),
spirometry values and bronchoscopic findings should be
included. Both the transverse and sagittal measurements of
trachea 2 cm above aortic arch, and the size of the left and
right main bronchus should be given. This would eventually
allow evaluating the characteristics of this syndrome more
thoroughly.
For the treatment of MKS, the use of guidelines of non-
cystic fibrosis bronchiectatic disease [29] and guidelines for
lower respiratory tract infections [30] seem to be in place
so that an appropriate antibiotic regiment upon exacer-
bations could be chosen. In the same time pathologic
changes in airways caused by MKS may complicate the
treatment of even community acquired pneumonia and
may cause treatment resistance [23]. There is no data on
prophylactic antibiotics use; therefore they should be
applied according to the general guidelines. And finally, the
authors suggest that vaccination for influenza and pneu-
mococci should extend to all adult patients diagnosed with
the condition regardless of their age or presence of
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